在肺高血压中,瑞诺丁受体2功能障碍和FK506结合蛋白之间的交叉交互
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, V. L. Mehta Road, Mithibai campus, Vile Parle west, Mumbai, 400056, Maharashtra, India.
Cardiovascular drugs and therapy
|December 13, 2025
概括
肺高血压涉及平滑肌肉细胞中的调节失调. 针对RyR2 / FKBP12.6不稳定路径可能会改善这种心血管疾病的管理.
科学领域:
- 心血管研究研究心血管研究
- 细胞生物学 细胞生物学
- 线粒体医学 线粒体医学
背景情况:
- 肺高血压 (PH) 是一种复杂的心血管疾病,其特点是高肺动脉压和血管重塑.
- 在PH中,瑞诺丁受体2 (RyR2) 和FK506结合蛋白12.6 (FKBP12.6) 在缺氧下解离,导致肺动脉光滑肌细胞 (PASMC) 中的 (Ca2+) 失衡.
研究的目的:
- 审查线粒体反应性氧物种 (ROS) 的作用,特别是通过瑞斯克铁硫蛋白 (RISP),激活RyR2.
- 为了探索线粒体功能障碍和sarcoplasmic网膜信号传递在PH病变发生的联系.
- 为了强调这种信号如何促进血管收缩和血管重塑.
主要方法:
- 对研究RyR2,FKBP12.6,线粒体ROS和肺高血压中信号的文献综述.
- 在PASMC中,分析将线粒体功能与处理联系起来的分子机制.
- 检查涉及PH进展的途径和潜在的治疗点.
主要成果:
- 以RISP为媒介的线粒体ROS直接触发RyR2激活和随后的Ca2+释放.
- 在线粒体功能障碍和异常的肉质细胞网膜Ca2+信号之间建立了显著的联系.
- 这种信号级联促进肺血管收缩和血管重塑,这是PH的关键特征.
结论:
- RyR2 / FKBP12.6复合体的不稳定是肺高血压进展的关键因素.
- 针对这些特定的分子通路提供了一个有希望的治疗策略来管理PH.
- 了解线粒体和信号传递之间的相互作用对于开发新型PH治疗至关重要.
更多相关视频
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
411
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
411
01:26Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.3K
01:23Rheumatic Heart Disease I: Introduction
400
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
400
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K